General Electric Co
Change company Symbol lookup
Select an option...
GE General Electric Co
GTPBU Gores Technology Partners II Inc
IRBT iRobot Corp
NRG NRG Energy Inc
FRLAU Fortune Rise Acquisition Corp
BTBT Bit Digital Inc
RUMBW Rumble Equity Warrant Exp 16th Sept 2027 *W EXP 09/16/2027
RSLS ReShape Lifesciences Inc
BWA Borgwarner Inc
CSCO Cisco Systems Inc
Go

Industrials : Industrial Conglomerates | Large Cap Value
Company profile

General Electric Company is an industrial company. The Company operates through its industrial segments, Power, Renewable Energy, Aviation and Healthcare, and its financial services segment, Capital. Its segments include Power, which serves power generation, industrial, government and other customers with products and services related to energy production; Renewable Energy, which provides solutions for renewable energy; Aviation, which includes commercial and military aircraft engines, and integrated digital components, electric power and mechanical aircraft systems; Healthcare, which provides healthcare technologies in medical imaging, digital solutions, patient monitoring and diagnostics, and drug discovery, and Capital, which is a financial services division. Its products include commercial and military aircraft engines and systems; healthcare systems and pharmaceutical diagnostics; wind and other renewable energy generation equipment; nuclear and other power generation equipment.

Postmarket

Last Trade
Delayed
$64.35
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$64.35
Day's Change
-0.12 (-0.19%)
Bid
--
Ask
--
B/A Size
--
Day's High
66.16
Day's Low
64.21
Volume
(Heavy Day)
Volume:
10,453,131

10-day average volume:
7,173,373
10,453,131

Retooled, omicron-specific COVID boosters expected in September: report

9:34 pm ET July 28, 2022 (MarketWatch)
Print

By Mike Murphy

Biden administration decides those under 50 should wait for the new shot for their second booster, New York Times reports

The Biden administration is tweaking its COVID booster plans, according to a new report, and now expects to roll out retooled Pfizer and Moderna shots in September that could perform better against the omicron BA.5 subvariant.

The New York Times reported Thursday night that federal officials have decided against expanding second-booster eligibility for adults under 50 right now -- a plan that was reportedly under discussion earlier this month -- and instead begin a new booster campaign for all adults in September.

The reasoning is that it'll be worth it for those under 50 to wait slightly longer for the improved booster, rather than expand eligibility now with the older shot. While the older version is still highly effective at preventing serious symptoms and death, the new, omicron-specific boosters are expected to provide better defense against BA.5, though data on that is still preliminary.

The Times reported that the decision was made after Pfizer Inc. (PFE) and Moderna Inc. (MRNA) promised they could deliver enough doses by September.

All adults are expected to be eligible for the new boosters, and children may get approval too, the Times reported. Currently, second boosters are only available to those 50 and over, or those 12 and over who are immunocompromised.

-Mike Murphy

	

(END) Dow Jones Newswires

July 28, 2022 21:34 ET (01:34 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.